Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]
Gnann DC +3 more
europepmc +1 more source
Daratumumab for CD20<sup>-</sup>CD38<sup>+</sup> Relapsed/Refractory Diffuse Large B-Cell Lymphoma. [PDF]
Hong Z +9 more
europepmc +1 more source
Successful Salvage Therapy with Pomalidomide, Cyclophosphamide, and Dexamethasone for IgM Myeloma with t (11;14) and Dim CD38 Expression Refractory to Daratumumab, Lenalidomide, and Dexamethasone. [PDF]
Fujishima T +5 more
europepmc +1 more source
Inhibition of CD38 by 78c Enhanced NAD<sup>+</sup>, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens. [PDF]
Cao K +5 more
europepmc +1 more source
Identification of Serum BST1 as a Biomarker to Predict Coronary Artery Lesions in Children with Kawasaki Disease Based on 4D-DIA Quantitative Proteomics. [PDF]
Zhang S +5 more
europepmc +1 more source
The Sirt3-CD38 axis induces mitochondrial dysfunction in hypertrophied heart by regulating mitochondrial calcium overload. [PDF]
Liu J, Liu N, Qi C, Dong D, Liu B.
europepmc +1 more source
Targeting CD38 in Antibody-Mediated Rejection. [PDF]
Mayer KA +4 more
europepmc +1 more source

